Skip to main content
Commentary

The quest to eliminate intrathecal vincristine errors: a 40-year journey.

Noble DJ, Donaldson LJ. The quest to eliminate intrathecal vincristine errors: a 40-year journey. Qual Saf Health Care. 2010;19(4)(4):323-326. doi:10.1136/qshc.2008.030874.

Save

Print

March 31, 2010
Noble DJ, Donaldson LJ. Qual Saf Health Care. 2010;19(4):323-326.

Accidental administration of the intravenous chemotherapy agent vincristine into the sac around the spinal cord is almost invariably fatal. This error has been recognized since vincristine was first used in the 1960s and is now classified as a never event, but it has not been eliminated despite vigorous efforts. This article reviews the history of safety initiatives around vincristine and identifies five domains of failure, ranging from failure to adequately investigate cases to failure to translate safety solutions internationally. A fatal vincristine error that occurred in the United Kingdom was the subject of a detailed investigation commissioned by the National Health Service. One of this article's authors, Sir Liam Donaldson, was interviewed by AHRQ WebM&M in 2007.

Save

Print

Cite
Citation

Noble DJ, Donaldson LJ. The quest to eliminate intrathecal vincristine errors: a 40-year journey. Qual Saf Health Care. 2010;19(4)(4):323-326. doi:10.1136/qshc.2008.030874.